Quick Takeaways: Why It Matters? By putting TRUFORMA analyzers in equine clinics at no cost and offering free PPID testing cartridges to eligible Boehringer Ingelheim customers, the program makes it much easier and faster for vets to diagnose and monitor Cus...
Quick Takeaways: Why It Matters? Boehringer Ingelheim’s purchase of Evax gives it a promising new way to treat common horse allergies with longer‑lasting vaccines instead of short‑term symptom relief, which could mean fewer vet visits and better outcomes for owners. If the approach works a...
Quick Takeaways: Why It Matters? The EUA makes ivermectin liquid a short-term, horse-only screwworm prophylaxis tool, adding another regulated option to the NWS armamentarium and slightly strengthening biosecurity for foals and wounded horses, but because protection lasts only 24 hours and...
Quick Takeaways Why It Matters? AgmaVet For Horses gives vets and owners a non-NSAID, nutraceutical option for managing lameness and mobility, which may appeal where long-term drug side effects are a concern. By targeting both nerve function and joint healt...
Quick Takeaways: Why It Matters? The recall may temporarily weaken confidence in Neogen’s veterinary portfolio and open space for rival hyaluronate or wound-care products. It also underscores regulatory and safety scrutiny around off-label use, likely prompting v...
Dechra Secures FDA Approval for Zygolide (Pergolide) in Equine Pituitary Pars Intermedia Dysfunction
Quick Takeaways: Why It Matters? Zygolide gives vets and owners a lower-cost, FDA-approved alternative for managing PPID, which should improve treatment uptake in senior horses. The focus on flexible dosing and palatability makes long-term therapy more practical in th...
